Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Hiromichi, Murayama"'
Autor:
Kazuaki Kameda, Ryo Yanagiya, Yuji Miyatake, Joaquim Carreras, Hiroshi Higuchi, Hiromichi Murayama, Takashi Ishida, Asahi Ito, Shinsuke Iida, Noriko Fukuhara, Hideo Harigae, Yuki Fujioka, Naoto Takahashi, Hidenori Wada, Fumihiro Ishida, Hideyuki Nakazawa, Rei Ishihara, Yuki Murakami, Hiroyuki Tagawa, Tadashi Matsuura, So Nakagawa, Sadahiro Iwabuchi, Shinichi Hashimoto, Ken-Ichi Imadome, Naoya Nakamura, Kenichi Ishizawa, Yoshinobu Kanda, Kiyoshi Ando, Ai Kotani
Publikováno v:
Blood Journal.
Aggressive natural killer cell leukemia (ANKL) is a rare lymphoid neoplasm frequently associated with Epstein-Barr virus, with a disastrously poor prognosis. Owing to the lack of samples from patients with ANKL and relevant murine models, comprehensi
Autor:
Jun Amaki, Hiromichi Matsushita, Yuka Kitamura, Ryoko Nagao, Hiromichi Murayama, Minoru Kojima, Kiyoshi Ando
Publikováno v:
Leukemia Research Reports, Vol 5, Iss C, Pp 14-17 (2016)
We experienced the case of a 56-year-old male with B-lymphoid/myeloid lineage mixed phenotype acute leukemia (MPAL). A cytogenetic analysis of the patient's bone marrow revealed a complex karyotype, including der(9)t(7;9)(q11.2;p13). We identified an
Externí odkaz:
https://doaj.org/article/6eb55791fc97443cb84bb85a777f33cf
Autor:
Yuka Kitamura, Minoru Kojima, Ryoko Nagao, Hiromichi Matsushita, Hiromichi Murayama, Jun Amaki, Kiyoshi Ando
Publikováno v:
Leukemia Research Reports, Vol 5, Iss C, Pp 14-17 (2016)
Leukemia Research Reports
Leukemia Research Reports
We experienced the case of a 56-year-old male with B-lymphoid/myeloid lineage mixed phenotype acute leukemia (MPAL). A cytogenetic analysis of the patient's bone marrow revealed a complex karyotype, including der(9)t(7;9)(q11.2;p13). We identified an
Autor:
Kosuke Tsuboi, Naoya Nakamura, Miharu Yabe, Tomoki Kikuchi, Minoru Kojima, Yoshiaki Ogawa, Yara Yukie Kikuti, Kiyoshi Ando, Hiromichi Murayama, Mami Tokunaka, Makiko Moriuchi
Publikováno v:
International Journal of Hematology. 101:520-524
We report a case of HIV-negative Burkitt lymphoma (BL) that relapsed 9 years after complete remission. We performed a polymerase chain reaction analysis of three regions of the VDJ junction of the immunoglobulin heavy chain (IGH) gene and compared th
Autor:
Daisuke Ohgiya, Yukari Shirasugi, Erika Matsusita, Eri Kikkawa, Yoshiaki Ogawa, Ken Ohmachi, Shinichiro Machida, Kiyoshi Ando, Hiroshi Kawada, Ryujiro Hara, Makoto Onizuka, Hiromichi Matsushita, Hiromichi Murayama, Yoshihiko Nakamura
Publikováno v:
International journal of hematology. 106(5)
A recent study reported that treatment-free remission (TFR) of chronic myeloid leukemia (CML) after dasatinib (Das) treatment was significantly associated with natural killer (NK) cell proliferation in the peripheral blood. However, biomarkers to pre
Publikováno v:
International Journal of Hematology. 104:637-638
Autor:
Hiroshi, Kawada, Masakazu, Sawanobori, Mitsuyo, Tsuma-Kaneko, Izumi, Wasada, Mitsuki, Miyamoto, Hiromichi, Murayama, Masako, Toyosaki, Makoto, Onizuka, Kosuke, Tsuboi, Kei, Tazume, Yukari, Shirasugi, Ken, Ohmachi, Yoshiaki, Ogawa, Hiroyuki, Kobayashi, Kiyoshi, Ando
Publikováno v:
The Tokai journal of experimental and clinical medicine. 39(3)
To determine the safety and the appropriate dose of intravenous l-ascorbic acid (AA) in conjunction with chemotherapy for patients with relapsed lymphoma.Patients with relapsed CD20-positive B-cell non-Hodgkin's lymphoma, who were going to receive th
Autor:
Yoshihiko Nakamura, Ryujiro Hara, Hiroshi Kawada, Daisuke Ogiya, Erika Matsusita, Hiromichi Murayama, Yoshiaki Ogawa, Yukari Shirasugi, Makoto Onizuka, Kiyoshi Ando, Ken Omachi, Eri Kikkawa
Publikováno v:
Blood. 128:3091-3091
Dasatinib (DA) is a tyrosine kinase inhibitor (TKI), and is approved for the treatment of naïve and relapsed/refractory Philadelphia chromosome positive leukemia. DA is a potent and multi-target TKI, and a part of patients treated with DA are report
Autor:
Rikio, Suzuki, Ako, Kikuchi, Daisuke, Ohgiya, Hiromichi, Murayama, Masako, Toyosaki, Takahiro, Suyama, Shigeki, Watanabe, Yoshiaki, Ogawa, Hiroshi, Kawada, Kiyoshi, Ando
Publikováno v:
The Tokai journal of experimental and clinical medicine. 34(3)
Acquired aplastic anemia is a rare hematopoietic stem-cell disorder that results in pancytopenia and hypocellular bone marrow. The pathophysiology is immune mediated in most cases, with activated type 1 cytotoxic T cells implicated. Acquired aplastic
Autor:
Kosuke, Tsuboi, Hiroshi, Kawada, Rikio, Suzuki, Hiromichi, Murayama, Ken, Ohmachi, Naoya, Nakamura, Yoshiaki, Ogawa, Kiyoshi, Ando
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 49(11)
A 71-year-old man presented with progressive dysuria. Several imaging examinations indicated possibility of prostate tumor, therefore he underwent prostate biopsy. This resulted in a diagnosis of granulocytic sarcoma of the prostate. Since bone marro